相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 免疫原:
Inhibitor of nuclear factor kappa-B kinase subunit epsilon
- 亚型:
IgG
- 形态:
liquid
- 保存条件:
负20摄氏度
- 克隆性:
polyclonal
- 标记物:
Non-conjugated
- 适应物种:
Human, rat
- 保质期:
6个月
- 抗原来源:
Rabbit
- 目录编号:
P04085
- 级别:
纯化级别
- 库存:
50
- 供应商:
LSM bio
- 宿主:
E. coli - derived recombinant protein
- 应用范围:
ELISA, WB, IHC
- 浓度:
≥95% as determined by SDS-PAGE
- 靶点:
Inhibitor of nuclear factor kappa-B kinase subunit epsilon
- 抗体英文名:
sumo antibody
- 抗体名:
sumo antibody|sumo 抗体
- 规格:
100μl
sumo antibody
Product Name sumo antibody
Catalog No PAab10242
Packing 100ul
Form liquid
Alternative Name SMT3C, SMT3H3, UBL1
Purification Immunogen affinity purified
Purity 95% as determined by SDS-PAGE
Host Rabbit
Isotype IgG
Storage PBS with 0.02% sodium azide and 50% glycerol pH 7.3 , -20Centigrade for 24 months (Avoid repeated freeze / thaw cycles.)
Background/ FUNCTION
Immunogen Small ubiquitin-related modifier 1
Specificity Human, Mouse, Rat
Tested Application ELISA, WB, IHC
Recommended dilution WB: 1:500-1:2000; IHC: 1:50-1:200
IHC use Immunohistochemistry of paraffin-embedded mouse brain tissue slide using PAab10242(sumo antibody) at dilution of 1:100
WB use
A549 cells tissue were subjected to SDS PAGE followed by western blot with PAab10242(sumo antibody) at dilution of 1:1000
Protein Information
Gene ID
Uniprot ID P63165
Calculated MW 11 kDa
Research Area
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Post-translational modification by SUMO is now recognized as an important regulatory method employed by the cell to reversibly modulate the activity, stability, or localization of intracellular proteins. A dedicated enzymatic machinery
Inhibition of the SUMO Pathway by Gam1
We have previously demonstrated that Gam1, an avian adenoviral protein inhibits sumoylation. By counteracting the SUMO pathway, Gam1 has a significant impact on virus-infected cells, but in isolation the inhibitory effects of the Gam1 protein
The covalent modification of cellular factors by the small ubiquitin-like modifier (SUMO) has emerged as a key regulatory pathway for many biological processes. One recent advance in the field of SUMO modification that has provided important
技术资料暂无技术资料 索取技术资料








